ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Amgen Inc

Amgen Inc (0R0T)

336,25
-1,00
(-0,30%)
Geschlossen 22 September 5:30PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
336,25
Gebot
323,50
Fragen
349,00
Volumen
838
0,00 Tagesbereich 0,00
254,00 52-Wochen-Bereich 339,00
Marktkapitalisierung
Handelsende
337,25
Handelsbeginn
-
Letzte Trade
4
@
337.61
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
4.818
Ausgegebene Aktien
535.178.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
26,88
Gewinn pro Aktie (EPS)
12,55
Erlöse
28,19B
Nettogewinn
6,72B

Über Amgen Inc

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Amgen Inc is listed in the Biological Pds,ex Diagnstics sector of the Londoner Börse with ticker 0R0T. The last closing price for Amgen was US$337,25. Over the last year, Amgen shares have traded in a share price range of US$ 254,00 to US$ 339,00.

Amgen currently has 535.178.000 shares in issue. The market capitalisation of Amgen is US$180,49 billion. Amgen has a price to earnings ratio (PE ratio) of 26.88.

0R0T Neueste Nachrichten

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition PR Newswire Reykjavik, ICELAND, Nov. 6, 2023 Reykjavik, ICELAND, Nov. 6, 2023 /PRNewswire/ -- A...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 06 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Drugmakers agree to US government price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
15.251.58610271903331337.25331910334.46730769DE
45.751.7397881997330.5337.25321.52956329.40762341DE
1223.257.42811501597313339306.54818330.11590647DE
266624.4218316374270.253392644266317.29035625DE
5266.2524.53703703727033925423078293.31098171DE
156117.2553.538812785421933920222938255.81217978DE
260159.7890.5423018077176.47339176.4715246252.53975678DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BLVNBowleven Plc
0,275p
(57,14%)
945,06k
CZNCurzon Energy Plc
0,045p
(38,46%)
595,25M
GBPGlobal Petroleum Limited
0,125p
(35,14%)
637,49M
PPSProton Motor Power Systems Plc
0,60p
(33,33%)
1,41M
MOSMobile Streams Plc
0,1475p
(28,26%)
126,36M
NFXNuformix Plc
0,07p
(-54,84%)
93,6M
JADEJade Road Investments Limited
0,30p
(-40,00%)
1,06M
WSBNWishbone Gold Plc
0,375p
(-31,82%)
26,8M
CTAICatenai Plc
0,15p
(-30,23%)
38,77k
DOCSDr. Martens Plc
51,90p
(-19,03%)
22,48M
GBPGlobal Petroleum Limited
0,125p
(35,14%)
637,49M
CZNCurzon Energy Plc
0,045p
(38,46%)
595,25M
NTVONativo Resources Plc
0,0027p
(0,00%)
393,5M
MSMNMosman Oil And Gas Limited
0,035p
(2,94%)
363,54M
UKOGUk Oil & Gas Plc
0,041p
(-1,20%)
363,2M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock